In the past couple of years, the UK has witnessed a revolution in professional medical fat‑reduction treatments — from the introduction of semaglutide (Wegovy®) for the developing level of popularity of tirzepatide (Mounjaro®). Now, An additional identify is drawing attention in both scientific a